Table 1.
Patients’ characteristics and technical features of endoscopic ultrasound-guided choledocho- duodenostomy with fully covered self-expandable metallic stents
| No. | Age/sex | Diagnosis | Reason for failed ERCP | Diameter/length of FCSEMS (mm/mm) | Early adverse events | Late adverse events | Re-intervention |
| 1 | 74/M | Pancreatic cancer | Periampullary tumor infiltration | 8/40 | None | None | None |
| 2 | 63/F | Pancreatic cancer | Duodenal obstruction | 10/50 | None | Distal migration | Reinsertion of FCSEMS |
| 3 | 56/M | Pancreatic cancer | Periampullary tumor infiltration | 8/50 | Pneumoperitoneum | None | None |
| 4 | 78/F | Pancreatic cancer | Periampullary tumor infiltration | 8/60 | Pneumoperitoneum | None | None |
| 5 | 75/F | Pancreatic cancer | Periampullary tumor infiltration | 8/60 | None | Distal migration | Reinsertion of FCSEMS |
| 6 | 46/M | DLBL | Duodenal obstruction | 8/50 | None | None | None |
| 7 | 91/M | AOV cancer | Periampullary tumor infiltration | 8/60 | None | Distal migration | Reinsertion of FCSEMS |
| 8 | 59/F | RCC | Duodenal obstruction | 8/60 | None | Distal migration | None |
| 9 | 30/M | Pancreatic cancer | Duodenal obstruction | 8/50 | None | None | None |
| 10 | 68/M | AOV cancer | Periampullary tumor infiltration | 8/50 | None | None | None |
| 11 | 54/F | Pancreatic cancer | Periampullary tumor infiltration | 8/60 | None | None | None |
| 12 | 45/F | AGC | Periampullary tumor infiltration | 8/60 | Cholangitis | None | Repositioning of stent |
| 13 | 58/M | Duodenal cancer | Duodenal obstruction | 8/60 | None | None | None |
F: Female; M: Male; ERCP: Endoscopic retrograde cholangiopancreatography; FCSEMS: Fully covered self-expandable metallic stent; DLBL: Diffuse large B-cell lymphoma; AOV: Ampulla of Vater; RCC: Renal cell carcinoma; AGC: Advanced gastric cancer.